HCC |
Hepatocellular carcinoma |
PLC |
Primary liver cancer |
HBV |
Hepatitis B virus |
HCV |
Hepatitis C virus |
NAFLD |
Non-alcoholic fatty liver disease |
cHCC-CCA |
Combined hepatocellular–cholangiocarcinoma |
CCA |
Cholangiocarcinoma |
K19 |
Keratin 19 |
K19+
|
Keratin 19 positive |
K19−
|
Keratin 19 negative |
YAP |
Yes-associated protein 1 |
WWTR1 |
WW domain-containing transcription regulator protein 1 |
TAZ |
Transcriptional co-activator with PDZ-binding motif |
MST1/2 |
STE20-like protein kinases 1/2 |
LATS1/2 |
Large tumor suppressor 1/2 |
Sav1 |
Salvador 1 |
MOB1A/B |
Mob kinase activator 1A |
DFS |
Disease-free survival |
OS |
Overall survival |
ASH |
Alcoholic steatohepatitis |
NASH |
Nonalcoholic steatohepatitis |
PBC |
Primary biliary cholangitis |